Repligen Corporation to Present at Upcoming Investor Conferences
- Craig-Hallum’s 19th Annual Institutional Investor conference being held
June 1 . Management will be hosting one-on-one meetings with investors who are registered to attend the conference. - William Blair’s 42nd Annual Growth Stock Conference being held in
Chicago June 6-9 .Tony J. Hunt , President and Chief Executive Officer, is scheduled to present a company overview onJune 7, 2022 at10:40 a.m. CDT . - Jefferies’ Global Healthcare Conference being held in
New York June 8-10 .Jon K. Snodgres , Chief Financial Officer, is scheduled to present a company overview onJune 9, 2022 at9:30 a.m. EDT .
A live webcast of the William Blair and Jefferies conference presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation (RGEN)
Repligen Corporation (RGEN) is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. We are inspiring advances in bioprocessing for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our corporate headquarters are located in
Repligen Contact:
Global Head of Investor Relations
(781) 419-1881
investors@repligen.com
Image: https://www.globenewswire.com/newsroom/ti?nf=ODU1OTM3NiM0OTQ1OTMwIzIwMDUyMzg=
Image: https://ml.globenewswire.com/media/ZTQ5N2U1ODYtN2EzNi00MjM4LWI2YTctZDA2MjhlZDQwOWJlLTEwMTY4MTE=/tiny/Repligen-Corporation.png
Image: Primary Logo
Source: Repligen Corporation (RGEN)